SlideShare a Scribd company logo
Basics of insulin therapy
Mohsen Eledrisi, MD, FACP, FACE
Department of Medicine
Hamad Medical Corporation
Doha, Qatar
eledrisi@yahoo.com
‫الرحيم‬ ‫الرحمن‬ ‫هللا‬ ‫بسم‬
Banting & Best
The discovery of insulin
1921: Isletin isolated
1922:
1st human experiment
1923:
Name changed to “Insulin”
Insula (latin) = island
Insulin secretion
Polonsky K et al. New Eng J Med 1988;318:1231
10
20
30
50
40
SerumInsulin
mcU/ml
Breakfast
Basal insulin
Lunch Dinner
Meal insulin
Types of Insulin
• Basal insulin
• Meal insulin
Basal insulin
Intermediate –acting:
NPH (Humulin N®, Insulatard® )
Long-acting:
Glargine U-100 (Lantus®)
Glargine U-300 (Toujeo®)
Glargine biosimilar (Basaglar ®)
Detemir (Levemir ®)
Degludec (Tresiba®)
NPH Insulin
(Neutral Protamine Hagedorn)
Humulin N®
Insulatard®
Looks cloudy
(Like milk)
Insulin Glargine U-100
(Lantus®)
Looks CLEAR
Like water
- Gray pen
- Vial with purple
top
Insulin Glargine U-300
(Toujeo®)
CLEAR
Like water
White pen with green top
Glargine biosimilar
(Basaglar®, Abasaglar®)
Insulin Detemir
(Levemir®)
Insulin Degludec
(Tresiba®)
U-100 & U-200
Meal Insulin
• Short-acting:
Regular (Actrapid®, Humulin R®, Novolin R®)
• Rapid-acting: (analogs)
- Lispro (Humalog®)
- Aspart (Novorapid®, Novolog®)
- Glulisine (Apidra®)
All look clear (like water)
Regular insulin
Actrapid ®
Humulin® R
Novolin® R
Insulin Regular U-500
(Humulin R® U-500)
Insulin Lispro
(Humalog®)
U-100 & U-200
Insulin Aspart
[Novorapid®]
(Novolog® in USA)
Insulin Glulisine
[Apidra®]
Action Profile of Insulins
0 1 2 53 4 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24
Plasma
insulin
levels
Regular
NPH
Hours
Glargine, Degludec
Lispro, Aspart, Glulisine
Detemir
Hirsch I. New Eng J Med 2005;352:174
Premixed insulins
• NPH/R 70/30
• Aspart 70/30
• Aspart 50/50
• Lispro 75/25
• Lispro 50/50
All premixed insulins look cloudy
(like milk)
NPH/R 70/30
Mixtard® 30
Contains 70 % NPH + 30 % Regular
Mixtard® 30
Mixtard® 30/70
Contains 70 % NPH + 30 % Regular
NPH/R 70/30
Humulin® 70/30
Lispro 75/25
(Humalog® 25, Humalog Mix 75/25®)
Contains 75 % Lispro protamine + 25 % Lispro
Lispro 50/50
(Humalog® 50, Humalog Mix 50/50®)
Contains 50 % Lispro protamine + 50 % Lispro
Insulin Aspart 70/30
(Novomix® 30)
(Novolog® mix 70/30 in USA)
Contains 70 % Aspart protamine + 30 % Aspart
Insulin Aspart 50/50
(Novomix® 50)
Contains 50 % Aspart protamine + 50 % Aspart
Combination
Degludec/Aspart
(Ryzodeg®)
Combination
Degludec/Liraglutide
(Xultophy®)
Combination
Glargine/Lixisenatide
(Soliqua®)
Indications for insulin
• Failure of non-insulin glucose-lowering therapy
• Type 1 DM
• Type of DM is not known
• Pregnancy
• Significant symptomatic hyperglycemia (random ≥ 300 mg)
or A1c ≥ 10
• In-hospital
Insulin vials
• “U-100 “ = every 1 ml has 100 units
• 1 vial has 10 ml = 1000 units
• New bottles should be kept in refrigerator [2-8 C)
[not freezer] until expiration date
• Opened vials are valid for 4 weeks
• Opened vials can be kept in refrigerator or in room
temperature (15-25 C)
Care of insulin vials
• Do not keep in hot places.
• Do not keep in a freezer.
• Do not leave in sunlight.
• Never use insulin if expired.
• Write the date on the insulin vial on the day you open it
or start keeping it outside the fridge. Throw the insulin
away 4 weeks after opened or since kept out of the
fridge.
• Inspect your insulin before each use. Look for changes
in color or clarity. Look for clumps, solid white particles
or crystals in the bottle or pen. Insulin that is clear should
always be clear and never look cloudy.
Insulin syringes
50 units
(0.5 ml)
100 units
(1 ml)
50-units insulin syringe
• Lines arranged in order of 5
(5, 10, 15,….)
• Every line equals one unit of insulin
Example: when injecting 12
units, you draw TWO
lines after line 10
10
15
100-units insulin syringe
• lines arranged in order of 10
(10, 20, 30….)
• Every line equals two units
of insulin
Example: when injecting 12
units, you draw ONE line
after line 10
10
20
• There are 2 types of pens:
1) Reusable (cartridges are changed)
- Pen stays
2) Disposable:
- Whole pen is changed
• Keep new disposable pen or cartridges
in refrigerator
• Once pen or cartridge is opened, keep
in room temperature (validity depends on type)
Insulin pens
Insulin pen care
• Insulin pens must be stored at room temperature:
Storing your insulin pen in extreme temperatures can lead to
changes in the concentration of the pen's insulin.
• Do not share your insulin pen with anyone: even if you are
changing the needles. Infections (HBV, HIV) happened as
insulin itself can be contaminated
• Do not withdraw insulin from the pen cartridge:
can lead to inaccurate dose measurement the next time the
insulin pen is used for dose delivery. The reason for this is
related to air entering the pen unintentionally, interfering with
the proper mechanics of the pen
Insulin pen care
• Do not leave an open needle attached to an insulin pen
It can lead to unintentional air entering into the insulin pen and
ultimately improper dosing of insulin. It could also lead to
insulin contamination.
• Proper insulin pen mixing:
Every time you use a pen containing NPH or premixed
mixtures . The insulin should look uniformly cloudy or milky
after mixing. If there are clumps floating in the insulin, or
white particles stuck to the bottom or sides of the pen giving
it a frosted look, don't use it.
How long is the opened pen or
unopened pen outside the
refrigerator valid for ?
• Aspart, Lispro, Glulisine: 4 weeks
• NPH: 2 weeks
• Glargine: 4 weeks
• Detemir: 6 weeks
• Degludec: 8 weeks
• Aspart 70/30: 2 weeks
• Premixed 70/30, Lispro 75/25, Lispro 50/50: 10 days
Sites of Insulin Injection
Abdomen, Arms ,Thighs
** Rotate injection sites
What time to give insulin?
NPH:
- At bedtime
- Or usually twice/day (usually mixed with meal insulin)
Glargine/Detemir:
- At bedtime (or AM)
- Some need twice daily
Degludec:
- Once daily (at same time of the day)
What time to give insulin?
Regular:
- 30 minutes before meals (once, twice or 3 times/day)
Rapid-acting insulins:
- 5 minutes before meals (once, twice or 3 times/day)
- Can be given immediately after meals
What time to give insulin?
Premixed 70/30 (Mixtard® 30 or Humulin® 70/30)
- 30 minutes before meals (once, twice or 3 times/day)
Aspart 70/30, Lispro 75/25, Lispro 50/50:
- 5 minutes before meals (once, twice or 3 times/day)
Which insulin to use?
Depends on:
Glucose control
Patient characteristics
Lifestyle
Patient preference
Insulin regimens in DM 2
Bedtime
Basal long-acting once/day
Insulin regimens in DM 2
Bedtime
Basal intermediate once/day
Insulin regimens in DM 2
Bedtime
Basal intermediate twice/day
Breakfast
Insulin regimens in DM 2
Lunch Bedtime
1 Basal + 1 Meal
BasalMeal
Insulin regimens in DM 2
Lunch Dinner Bedtime
1 Basal + 2 Meals
BasalMeal Meal
Insulin regimens in DM 2
Breakfast Lunch Dinner Bedtime
1 Basal + 3 Meals
BasalMealMeal Meal
Insulin regimens in DM 2
Breakfast Lunch Dinner
2 Basal + 3 Meals
Meal Basal + mealBasal + meal
Insulin regimens in DM 2
Breakfast Dinner
2 Intermediate + 2 Meals
Insulin regimens in DM 2
Breakfast Dinner
2 Intermediate + 3 Meals
Lunch
Insulin regimens in DM 2
Breakfast Dinner
3 Intermediate + 3 Meals
Lunch
Insulin regimens in DM 2
Breakfast Dinner
2 Premixed /day
Insulin regimens in DM 2
Breakfast Lunch Dinner
3 Premixed /day

More Related Content

What's hot

Recent advances in the management of Diabetes Mellitus
Recent advances in the management of Diabetes MellitusRecent advances in the management of Diabetes Mellitus
Recent advances in the management of Diabetes Mellitus
ShailaBanu3
 
Insulin therapy in primary health care DrMajdi
Insulin therapy in primary health care DrMajdiInsulin therapy in primary health care DrMajdi
Insulin therapy in primary health care DrMajdi
Dr. Majdi Al Jasim
 
UFH & LMWH & fondaparinux
UFH & LMWH & fondaparinuxUFH & LMWH & fondaparinux
UFH & LMWH & fondaparinux
Mohammed Adel
 
Insulin initiation adjustment
Insulin initiation adjustmentInsulin initiation adjustment
Insulin initiation adjustment
Bangabandhu Sheikh Mujib Medical University
 
Sodium glucose co transporter( SGLT2) Inhibitors
Sodium glucose co transporter( SGLT2) Inhibitors Sodium glucose co transporter( SGLT2) Inhibitors
Sodium glucose co transporter( SGLT2) Inhibitors
Philip Vaidyan
 
Management of Diabetes.pptx
Management of Diabetes.pptxManagement of Diabetes.pptx
Management of Diabetes.pptx
Oriba Dan Langoya
 
Combination therapy in hypertension
Combination therapy in hypertensionCombination therapy in hypertension
Combination therapy in hypertension
Dr Pradip Mate
 
Insulin: what is new ?
Insulin: what is new ?Insulin: what is new ?
Insulin: what is new ?
Mohammad Othman Daoud
 
Insulin therapy in type 2 diabetes
Insulin therapy in type 2 diabetesInsulin therapy in type 2 diabetes
Insulin therapy in type 2 diabetes
Mohsen Eledrisi
 
Insulin therapy
Insulin therapyInsulin therapy
Insulin therapy
Jeena Jose
 
SGLT2i
SGLT2iSGLT2i
SGLT2i
dibufolio
 
Dpp4i earlier the better ! (1)
Dpp4i  earlier the better ! (1)Dpp4i  earlier the better ! (1)
Dpp4i earlier the better ! (1)
Faraz Farishta
 
Management of diabetes mellitus
Management of diabetes mellitusManagement of diabetes mellitus
Management of diabetes mellitus
Samee Adnan
 
Insulin Presentation-Gulu.pptx
Insulin Presentation-Gulu.pptxInsulin Presentation-Gulu.pptx
Insulin Presentation-Gulu.pptx
DeriqueJoshua2
 
SGLT2I The paradigm change in diabetes management
SGLT2I The paradigm change in diabetes managementSGLT2I The paradigm change in diabetes management
SGLT2I The paradigm change in diabetes management
Praveen Nagula
 
Insulin22
Insulin22Insulin22
Insulin22
Praveen Nagula
 
Sglt2 inhibitors past present and future
Sglt2 inhibitors past present and futureSglt2 inhibitors past present and future
Sglt2 inhibitors past present and future
Priyanka Thakur
 
Basal insulin in T2DM
Basal insulin in T2DMBasal insulin in T2DM
Basal insulin in T2DM
Government of West Bengal
 
SGLT2 Inhibitors in Diabetes Management by Dr Shahjada Selim
SGLT2 Inhibitors in Diabetes Management by Dr Shahjada SelimSGLT2 Inhibitors in Diabetes Management by Dr Shahjada Selim
SGLT2 Inhibitors in Diabetes Management by Dr Shahjada Selim
Bangabandhu Sheikh Mujib Medical University
 
Newer anti diabetic drugs
Newer anti diabetic drugsNewer anti diabetic drugs
Newer anti diabetic drugs
Dr.Vijay Talla
 

What's hot (20)

Recent advances in the management of Diabetes Mellitus
Recent advances in the management of Diabetes MellitusRecent advances in the management of Diabetes Mellitus
Recent advances in the management of Diabetes Mellitus
 
Insulin therapy in primary health care DrMajdi
Insulin therapy in primary health care DrMajdiInsulin therapy in primary health care DrMajdi
Insulin therapy in primary health care DrMajdi
 
UFH & LMWH & fondaparinux
UFH & LMWH & fondaparinuxUFH & LMWH & fondaparinux
UFH & LMWH & fondaparinux
 
Insulin initiation adjustment
Insulin initiation adjustmentInsulin initiation adjustment
Insulin initiation adjustment
 
Sodium glucose co transporter( SGLT2) Inhibitors
Sodium glucose co transporter( SGLT2) Inhibitors Sodium glucose co transporter( SGLT2) Inhibitors
Sodium glucose co transporter( SGLT2) Inhibitors
 
Management of Diabetes.pptx
Management of Diabetes.pptxManagement of Diabetes.pptx
Management of Diabetes.pptx
 
Combination therapy in hypertension
Combination therapy in hypertensionCombination therapy in hypertension
Combination therapy in hypertension
 
Insulin: what is new ?
Insulin: what is new ?Insulin: what is new ?
Insulin: what is new ?
 
Insulin therapy in type 2 diabetes
Insulin therapy in type 2 diabetesInsulin therapy in type 2 diabetes
Insulin therapy in type 2 diabetes
 
Insulin therapy
Insulin therapyInsulin therapy
Insulin therapy
 
SGLT2i
SGLT2iSGLT2i
SGLT2i
 
Dpp4i earlier the better ! (1)
Dpp4i  earlier the better ! (1)Dpp4i  earlier the better ! (1)
Dpp4i earlier the better ! (1)
 
Management of diabetes mellitus
Management of diabetes mellitusManagement of diabetes mellitus
Management of diabetes mellitus
 
Insulin Presentation-Gulu.pptx
Insulin Presentation-Gulu.pptxInsulin Presentation-Gulu.pptx
Insulin Presentation-Gulu.pptx
 
SGLT2I The paradigm change in diabetes management
SGLT2I The paradigm change in diabetes managementSGLT2I The paradigm change in diabetes management
SGLT2I The paradigm change in diabetes management
 
Insulin22
Insulin22Insulin22
Insulin22
 
Sglt2 inhibitors past present and future
Sglt2 inhibitors past present and futureSglt2 inhibitors past present and future
Sglt2 inhibitors past present and future
 
Basal insulin in T2DM
Basal insulin in T2DMBasal insulin in T2DM
Basal insulin in T2DM
 
SGLT2 Inhibitors in Diabetes Management by Dr Shahjada Selim
SGLT2 Inhibitors in Diabetes Management by Dr Shahjada SelimSGLT2 Inhibitors in Diabetes Management by Dr Shahjada Selim
SGLT2 Inhibitors in Diabetes Management by Dr Shahjada Selim
 
Newer anti diabetic drugs
Newer anti diabetic drugsNewer anti diabetic drugs
Newer anti diabetic drugs
 

Similar to Insulin basics.p

insulinbasics-190212181714.pdf
insulinbasics-190212181714.pdfinsulinbasics-190212181714.pdf
insulinbasics-190212181714.pdf
ssuserd131ec
 
Insulin Ce
Insulin CeInsulin Ce
Insulin Ce
Jaymax13
 
Inectables of diabetes
Inectables of diabetesInectables of diabetes
Inectables of diabetes
Government of West Bengal
 
Insulin awareness
Insulin awarenessInsulin awareness
Insulin awareness
Gaurav Bhatia
 
Insulin therapy and glucose monitoring
Insulin therapy and glucose monitoringInsulin therapy and glucose monitoring
Insulin therapy and glucose monitoring
Prasanth Kallampally
 
Insulin therapy in IDDM by Dr. Dilip
Insulin therapy in IDDM by Dr. DilipInsulin therapy in IDDM by Dr. Dilip
Insulin therapy in IDDM by Dr. Dilip
DrDilip86
 
Proper and safe use of Insulin
Proper and safe use of InsulinProper and safe use of Insulin
Proper and safe use of Insulin
Sanket Sahu
 
Insulin admin
Insulin adminInsulin admin
Insulin admin
kelvinaquino1984
 
Insulin and Other Injectables: At a Glance
Insulin and Other Injectables: At a GlanceInsulin and Other Injectables: At a Glance
Insulin and Other Injectables: At a Glance
Liberty Medical
 
INSULIN BY DR RASIK.ppt
INSULIN BY DR RASIK.pptINSULIN BY DR RASIK.ppt
INSULIN BY DR RASIK.ppt
Mohamed Rasik
 
Insulin by Nurse Practitioner
Insulin by Nurse PractitionerInsulin by Nurse Practitioner
Insulin by Nurse Practitioner
AMINDHULE
 
Patient Counseling of Antihyperlipidemic drugs
Patient Counseling of Antihyperlipidemic drugsPatient Counseling of Antihyperlipidemic drugs
Patient Counseling of Antihyperlipidemic drugs
Mohamed Mohsen Torya
 
DIABETES MELLITUS.pdf
DIABETES MELLITUS.pdfDIABETES MELLITUS.pdf
DIABETES MELLITUS.pdf
HimanshuRaj150
 
Proper Use of Diabetes Mellitus Devices
Proper Use of Diabetes Mellitus DevicesProper Use of Diabetes Mellitus Devices
Proper Use of Diabetes Mellitus Devices
Arwa M. Amin
 
Treatment of DM2 07-11-2023.pptx
Treatment of DM2 07-11-2023.pptxTreatment of DM2 07-11-2023.pptx
Treatment of DM2 07-11-2023.pptx
manjujanhavi
 
INSULIN DELIVERY METHODS _ For Medical/Pharma Students
INSULIN DELIVERY METHODS _ For Medical/Pharma StudentsINSULIN DELIVERY METHODS _ For Medical/Pharma Students
INSULIN DELIVERY METHODS _ For Medical/Pharma Students
Aaromal Satheesh
 
Diabetes Mellitus
Diabetes MellitusDiabetes Mellitus
Diabetes Mellitus
Sunita Kharel
 
INSULI THERAPY.pptx
INSULI THERAPY.pptxINSULI THERAPY.pptx
INSULI THERAPY.pptx
KIMS
 
insulindmravisir2ndtry-171206192100.pptx
insulindmravisir2ndtry-171206192100.pptxinsulindmravisir2ndtry-171206192100.pptx
insulindmravisir2ndtry-171206192100.pptx
MsccMohamed
 
INSULIN DELIVERY METHODS.pptx
INSULIN DELIVERY  METHODS.pptxINSULIN DELIVERY  METHODS.pptx
INSULIN DELIVERY METHODS.pptx
MsccMohamed
 

Similar to Insulin basics.p (20)

insulinbasics-190212181714.pdf
insulinbasics-190212181714.pdfinsulinbasics-190212181714.pdf
insulinbasics-190212181714.pdf
 
Insulin Ce
Insulin CeInsulin Ce
Insulin Ce
 
Inectables of diabetes
Inectables of diabetesInectables of diabetes
Inectables of diabetes
 
Insulin awareness
Insulin awarenessInsulin awareness
Insulin awareness
 
Insulin therapy and glucose monitoring
Insulin therapy and glucose monitoringInsulin therapy and glucose monitoring
Insulin therapy and glucose monitoring
 
Insulin therapy in IDDM by Dr. Dilip
Insulin therapy in IDDM by Dr. DilipInsulin therapy in IDDM by Dr. Dilip
Insulin therapy in IDDM by Dr. Dilip
 
Proper and safe use of Insulin
Proper and safe use of InsulinProper and safe use of Insulin
Proper and safe use of Insulin
 
Insulin admin
Insulin adminInsulin admin
Insulin admin
 
Insulin and Other Injectables: At a Glance
Insulin and Other Injectables: At a GlanceInsulin and Other Injectables: At a Glance
Insulin and Other Injectables: At a Glance
 
INSULIN BY DR RASIK.ppt
INSULIN BY DR RASIK.pptINSULIN BY DR RASIK.ppt
INSULIN BY DR RASIK.ppt
 
Insulin by Nurse Practitioner
Insulin by Nurse PractitionerInsulin by Nurse Practitioner
Insulin by Nurse Practitioner
 
Patient Counseling of Antihyperlipidemic drugs
Patient Counseling of Antihyperlipidemic drugsPatient Counseling of Antihyperlipidemic drugs
Patient Counseling of Antihyperlipidemic drugs
 
DIABETES MELLITUS.pdf
DIABETES MELLITUS.pdfDIABETES MELLITUS.pdf
DIABETES MELLITUS.pdf
 
Proper Use of Diabetes Mellitus Devices
Proper Use of Diabetes Mellitus DevicesProper Use of Diabetes Mellitus Devices
Proper Use of Diabetes Mellitus Devices
 
Treatment of DM2 07-11-2023.pptx
Treatment of DM2 07-11-2023.pptxTreatment of DM2 07-11-2023.pptx
Treatment of DM2 07-11-2023.pptx
 
INSULIN DELIVERY METHODS _ For Medical/Pharma Students
INSULIN DELIVERY METHODS _ For Medical/Pharma StudentsINSULIN DELIVERY METHODS _ For Medical/Pharma Students
INSULIN DELIVERY METHODS _ For Medical/Pharma Students
 
Diabetes Mellitus
Diabetes MellitusDiabetes Mellitus
Diabetes Mellitus
 
INSULI THERAPY.pptx
INSULI THERAPY.pptxINSULI THERAPY.pptx
INSULI THERAPY.pptx
 
insulindmravisir2ndtry-171206192100.pptx
insulindmravisir2ndtry-171206192100.pptxinsulindmravisir2ndtry-171206192100.pptx
insulindmravisir2ndtry-171206192100.pptx
 
INSULIN DELIVERY METHODS.pptx
INSULIN DELIVERY  METHODS.pptxINSULIN DELIVERY  METHODS.pptx
INSULIN DELIVERY METHODS.pptx
 

More from Mohsen Eledrisi

Dyslipidemia in diabetes
Dyslipidemia in diabetesDyslipidemia in diabetes
Dyslipidemia in diabetes
Mohsen Eledrisi
 
Non insulin glucose-lowering therapy in type 2 DM
Non insulin glucose-lowering therapy in type 2 DMNon insulin glucose-lowering therapy in type 2 DM
Non insulin glucose-lowering therapy in type 2 DM
Mohsen Eledrisi
 
Evaluation & management of dyslipidemia
Evaluation & management of dyslipidemia Evaluation & management of dyslipidemia
Evaluation & management of dyslipidemia
Mohsen Eledrisi
 
Management of dyslipidemia
Management of dyslipidemiaManagement of dyslipidemia
Management of dyslipidemia
Mohsen Eledrisi
 
Non insulin glucose-lowering therapy-p
Non insulin glucose-lowering therapy-pNon insulin glucose-lowering therapy-p
Non insulin glucose-lowering therapy-p
Mohsen Eledrisi
 
Diabetes: screening & diagnosis
Diabetes: screening & diagnosisDiabetes: screening & diagnosis
Diabetes: screening & diagnosis
Mohsen Eledrisi
 

More from Mohsen Eledrisi (6)

Dyslipidemia in diabetes
Dyslipidemia in diabetesDyslipidemia in diabetes
Dyslipidemia in diabetes
 
Non insulin glucose-lowering therapy in type 2 DM
Non insulin glucose-lowering therapy in type 2 DMNon insulin glucose-lowering therapy in type 2 DM
Non insulin glucose-lowering therapy in type 2 DM
 
Evaluation & management of dyslipidemia
Evaluation & management of dyslipidemia Evaluation & management of dyslipidemia
Evaluation & management of dyslipidemia
 
Management of dyslipidemia
Management of dyslipidemiaManagement of dyslipidemia
Management of dyslipidemia
 
Non insulin glucose-lowering therapy-p
Non insulin glucose-lowering therapy-pNon insulin glucose-lowering therapy-p
Non insulin glucose-lowering therapy-p
 
Diabetes: screening & diagnosis
Diabetes: screening & diagnosisDiabetes: screening & diagnosis
Diabetes: screening & diagnosis
 

Recently uploaded

micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
MedicoseAcademics
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
Swastik Ayurveda
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Oleg Kshivets
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
The Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in IndiaThe Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in India
Swastik Ayurveda
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Sex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skullSex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skull
ShashankRoodkee
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Dr. Madduru Muni Haritha
 
Management of Traumatic Splenic injury.pptx
Management of Traumatic Splenic injury.pptxManagement of Traumatic Splenic injury.pptx
Management of Traumatic Splenic injury.pptx
AkshaySarraf1
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 

Recently uploaded (20)

micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
The Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in IndiaThe Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in India
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
 
Sex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skullSex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skull
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
 
Management of Traumatic Splenic injury.pptx
Management of Traumatic Splenic injury.pptxManagement of Traumatic Splenic injury.pptx
Management of Traumatic Splenic injury.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 

Insulin basics.p

  • 1. Basics of insulin therapy Mohsen Eledrisi, MD, FACP, FACE Department of Medicine Hamad Medical Corporation Doha, Qatar eledrisi@yahoo.com ‫الرحيم‬ ‫الرحمن‬ ‫هللا‬ ‫بسم‬
  • 2. Banting & Best The discovery of insulin 1921: Isletin isolated 1922: 1st human experiment 1923: Name changed to “Insulin” Insula (latin) = island
  • 3. Insulin secretion Polonsky K et al. New Eng J Med 1988;318:1231 10 20 30 50 40 SerumInsulin mcU/ml Breakfast Basal insulin Lunch Dinner Meal insulin
  • 4. Types of Insulin • Basal insulin • Meal insulin
  • 5. Basal insulin Intermediate –acting: NPH (Humulin N®, Insulatard® ) Long-acting: Glargine U-100 (Lantus®) Glargine U-300 (Toujeo®) Glargine biosimilar (Basaglar ®) Detemir (Levemir ®) Degludec (Tresiba®)
  • 6. NPH Insulin (Neutral Protamine Hagedorn) Humulin N® Insulatard® Looks cloudy (Like milk)
  • 7. Insulin Glargine U-100 (Lantus®) Looks CLEAR Like water - Gray pen - Vial with purple top
  • 8. Insulin Glargine U-300 (Toujeo®) CLEAR Like water White pen with green top
  • 12. Meal Insulin • Short-acting: Regular (Actrapid®, Humulin R®, Novolin R®) • Rapid-acting: (analogs) - Lispro (Humalog®) - Aspart (Novorapid®, Novolog®) - Glulisine (Apidra®) All look clear (like water)
  • 18. Action Profile of Insulins 0 1 2 53 4 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 Plasma insulin levels Regular NPH Hours Glargine, Degludec Lispro, Aspart, Glulisine Detemir Hirsch I. New Eng J Med 2005;352:174
  • 19. Premixed insulins • NPH/R 70/30 • Aspart 70/30 • Aspart 50/50 • Lispro 75/25 • Lispro 50/50 All premixed insulins look cloudy (like milk)
  • 20. NPH/R 70/30 Mixtard® 30 Contains 70 % NPH + 30 % Regular Mixtard® 30 Mixtard® 30/70 Contains 70 % NPH + 30 % Regular
  • 22. Lispro 75/25 (Humalog® 25, Humalog Mix 75/25®) Contains 75 % Lispro protamine + 25 % Lispro
  • 23. Lispro 50/50 (Humalog® 50, Humalog Mix 50/50®) Contains 50 % Lispro protamine + 50 % Lispro
  • 24. Insulin Aspart 70/30 (Novomix® 30) (Novolog® mix 70/30 in USA) Contains 70 % Aspart protamine + 30 % Aspart
  • 25. Insulin Aspart 50/50 (Novomix® 50) Contains 50 % Aspart protamine + 50 % Aspart
  • 29. Indications for insulin • Failure of non-insulin glucose-lowering therapy • Type 1 DM • Type of DM is not known • Pregnancy • Significant symptomatic hyperglycemia (random ≥ 300 mg) or A1c ≥ 10 • In-hospital
  • 30. Insulin vials • “U-100 “ = every 1 ml has 100 units • 1 vial has 10 ml = 1000 units • New bottles should be kept in refrigerator [2-8 C) [not freezer] until expiration date • Opened vials are valid for 4 weeks • Opened vials can be kept in refrigerator or in room temperature (15-25 C)
  • 31. Care of insulin vials • Do not keep in hot places. • Do not keep in a freezer. • Do not leave in sunlight. • Never use insulin if expired. • Write the date on the insulin vial on the day you open it or start keeping it outside the fridge. Throw the insulin away 4 weeks after opened or since kept out of the fridge. • Inspect your insulin before each use. Look for changes in color or clarity. Look for clumps, solid white particles or crystals in the bottle or pen. Insulin that is clear should always be clear and never look cloudy.
  • 32. Insulin syringes 50 units (0.5 ml) 100 units (1 ml)
  • 33. 50-units insulin syringe • Lines arranged in order of 5 (5, 10, 15,….) • Every line equals one unit of insulin Example: when injecting 12 units, you draw TWO lines after line 10 10 15
  • 34. 100-units insulin syringe • lines arranged in order of 10 (10, 20, 30….) • Every line equals two units of insulin Example: when injecting 12 units, you draw ONE line after line 10 10 20
  • 35. • There are 2 types of pens: 1) Reusable (cartridges are changed) - Pen stays 2) Disposable: - Whole pen is changed • Keep new disposable pen or cartridges in refrigerator • Once pen or cartridge is opened, keep in room temperature (validity depends on type) Insulin pens
  • 36. Insulin pen care • Insulin pens must be stored at room temperature: Storing your insulin pen in extreme temperatures can lead to changes in the concentration of the pen's insulin. • Do not share your insulin pen with anyone: even if you are changing the needles. Infections (HBV, HIV) happened as insulin itself can be contaminated • Do not withdraw insulin from the pen cartridge: can lead to inaccurate dose measurement the next time the insulin pen is used for dose delivery. The reason for this is related to air entering the pen unintentionally, interfering with the proper mechanics of the pen
  • 37. Insulin pen care • Do not leave an open needle attached to an insulin pen It can lead to unintentional air entering into the insulin pen and ultimately improper dosing of insulin. It could also lead to insulin contamination. • Proper insulin pen mixing: Every time you use a pen containing NPH or premixed mixtures . The insulin should look uniformly cloudy or milky after mixing. If there are clumps floating in the insulin, or white particles stuck to the bottom or sides of the pen giving it a frosted look, don't use it.
  • 38. How long is the opened pen or unopened pen outside the refrigerator valid for ? • Aspart, Lispro, Glulisine: 4 weeks • NPH: 2 weeks • Glargine: 4 weeks • Detemir: 6 weeks • Degludec: 8 weeks • Aspart 70/30: 2 weeks • Premixed 70/30, Lispro 75/25, Lispro 50/50: 10 days
  • 39. Sites of Insulin Injection Abdomen, Arms ,Thighs ** Rotate injection sites
  • 40. What time to give insulin? NPH: - At bedtime - Or usually twice/day (usually mixed with meal insulin) Glargine/Detemir: - At bedtime (or AM) - Some need twice daily Degludec: - Once daily (at same time of the day)
  • 41. What time to give insulin? Regular: - 30 minutes before meals (once, twice or 3 times/day) Rapid-acting insulins: - 5 minutes before meals (once, twice or 3 times/day) - Can be given immediately after meals
  • 42. What time to give insulin? Premixed 70/30 (Mixtard® 30 or Humulin® 70/30) - 30 minutes before meals (once, twice or 3 times/day) Aspart 70/30, Lispro 75/25, Lispro 50/50: - 5 minutes before meals (once, twice or 3 times/day)
  • 43. Which insulin to use? Depends on: Glucose control Patient characteristics Lifestyle Patient preference
  • 44. Insulin regimens in DM 2 Bedtime Basal long-acting once/day
  • 45. Insulin regimens in DM 2 Bedtime Basal intermediate once/day
  • 46. Insulin regimens in DM 2 Bedtime Basal intermediate twice/day Breakfast
  • 47. Insulin regimens in DM 2 Lunch Bedtime 1 Basal + 1 Meal BasalMeal
  • 48. Insulin regimens in DM 2 Lunch Dinner Bedtime 1 Basal + 2 Meals BasalMeal Meal
  • 49. Insulin regimens in DM 2 Breakfast Lunch Dinner Bedtime 1 Basal + 3 Meals BasalMealMeal Meal
  • 50. Insulin regimens in DM 2 Breakfast Lunch Dinner 2 Basal + 3 Meals Meal Basal + mealBasal + meal
  • 51. Insulin regimens in DM 2 Breakfast Dinner 2 Intermediate + 2 Meals
  • 52. Insulin regimens in DM 2 Breakfast Dinner 2 Intermediate + 3 Meals Lunch
  • 53. Insulin regimens in DM 2 Breakfast Dinner 3 Intermediate + 3 Meals Lunch
  • 54. Insulin regimens in DM 2 Breakfast Dinner 2 Premixed /day
  • 55. Insulin regimens in DM 2 Breakfast Lunch Dinner 3 Premixed /day